Further data supporting more selective JAK inhibitors were presented by Scuto, et al. who demonstrated that the selective JAK2 inhibitor AZD1480 was able to inhibit STAT3 phosphorylation and induce apoptosis in MM cell lines as well as in PDX [75]. The gene discussed is STAT3; the disease is Miyoshi myopathy.